Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients

Understanding early innate immune responses to coronavirus disease 2019 (COVID-19) is crucial to developing targeted therapies to mitigate disease severity. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection elicits interferon expression leading to transcription of IFN-stimulated g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Benitez, Marcos J., Strich, Jeffrey R., Alehashemi, Sara, Stein, Sydney, Rastegar, Andre, de Jesus, Adriana Almeida, Bhuyan, Farzana, Ramelli, Sabrina, Babyak, Ashley, Perez-Valencia, Luis, Vannella, Kevin M., Grubbs, Gabrielle, Khurana, Surender, Gross, Robin, Hadley, Kyra, Liang, Janie, Mazur, Steven, Postnikova, Elena, Warner, Seth, Holbrook, Michael R., Busch, Lindsay M., Warner, Blake, Applefeld, Willard, Warner, Sarah, Kadri, Sameer S, Davey, Richard T, Goldbach-Mansky, Raphaela, Chertow, Daniel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681051/
https://www.ncbi.nlm.nih.gov/pubmed/36415460
http://dx.doi.org/10.1101/2022.11.08.22281846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681051/
https://www.ncbi.nlm.nih.gov/pubmed/36415460
http://dx.doi.org/10.1101/2022.11.08.22281846

Ejemplares similares